We are live on ! Find out more
PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
+19.99%
1 Year Est. Return
+20.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96.3M
AUM Growth
+$11.2M
Cap. Flow
-$150K
Cap. Flow %
-0.16%
Top 10 Hldgs %
54.39%
Holding
61
New
6
Increased
24
Reduced
18
Closed
8

Top Buys

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$5.53M
2
SAGE
Sage Therapeutics
SAGE
+$4.33M
3
EFOR
Everforth Inc
EFOR
+$1.66M
4
ABCB icon
Ameris Bancorp
ABCB
+$1.64M
5
ABM icon
ABM Industries
ABM
+$1.45M

Top Sells

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$3.05M
2
PFPT
Proofpoint, Inc.
PFPT
+$3.01M
3
ARRY
Array Biopharma Inc
ARRY
+$2.33M
4
IMMU
Immunomedics Inc
IMMU
+$2.33M
5
GVA icon
Granite Construction
GVA
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 22.35%
2 Industrials 19.7%
3 Financials 17.34%
4 Technology 9.34%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTI icon
1
Universal Technical Institute
UTI
$2.09B
$7.82M 8.12%
2,292,487
– –
GIFI
2
DELISTED
Gulf Island Fabrication
GIFI
$6.66M 6.92%
726,407
-73,339
-9% -$680K
ICPT
3
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$5.66M 5.88%
+50,601
New +$5.53M
SAGE
4
DELISTED
Sage Therapeutics
SAGE
$5.3M 5.51%
33,330
+29,896
+871% +$4.33M
AIMT
5
DELISTED
Aimmune Therapeutics
AIMT
$4.87M 5.06%
217,730
+24,303
+13% +$572K
AERI
6
DELISTED
Aerie Pharmaceuticals
AERI
$4.84M 5.03%
101,811
-9,690
-9% -$427K
GVP
7
DELISTED
GSE Systems, Inc.
GVP
$4.69M 4.87%
167,468
-2,414
-1% -$69.6K
PNFP icon
8
Pinnacle Financial Partners Inc
PNFP
$15B
$4.38M 4.55%
80,135
-2,127
-3% -$117K
ABCB icon
9
Ameris Bancorp
ABCB
$6.11B
$4.21M 4.37%
122,569
+43,969
+56% +$1.64M
MDGL icon
10
Madrigal Pharmaceuticals
MDGL
$12.4B
$3.93M 4.08%
31,356
+6,286
+25% +$781K
ISBC
11
DELISTED
Investors Bancorp, Inc.
ISBC
$3.75M 3.89%
316,103
+43,618
+16% +$526K
HOMB icon
12
Home BancShares
HOMB
$6.09B
$2.88M 2.99%
163,839
-56,593
-26% -$1.05M
ABM icon
13
ABM Industries
ABM
$2.77B
$2.58M 2.68%
71,022
+41,766
+143% +$1.45M
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.02M 2.1%
76,448
+42,452
+125% +$1.01M
HIL
15
DELISTED
Hill International, Inc. Common Stock
HIL
$1.94M 2.02%
666,003
-93,997
-12% -$301K
EFOR
16
Everforth Inc
EFOR
$752M
$1.92M 2%
30,288
+26,609
+723% +$1.66M
GVA icon
17
Granite Construction
GVA
$5.34B
$1.89M 1.96%
43,724
-42,173
-49% -$1.88M
EGHT icon
18
8x8 Inc
EGHT
$264M
$1.86M 1.93%
92,055
+39,175
+74% +$766K
SUM
19
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.7M 1.77%
109,158
-82,638
-43% -$1.29M
KIN
20
DELISTED
Kindred Biosciences, Inc.
KIN
$1.67M 1.73%
181,962
-92,802
-34% -$942K
PCH
21
DELISTED
PotlatchDeltic
PCH
$1.61M 1.68%
42,666
-580
-1% -$20.7K
NTB icon
22
Bank of N.T. Butterfield & Son
NTB
$2.41B
$1.47M 1.53%
41,010
+2,387
+6% +$85.7K
IMMU
23
DELISTED
Immunomedics Inc
IMMU
$1.25M 1.29%
64,759
-144,409
-69% -$2.33M
PLCE icon
24
Children's Place
PLCE
$58.7M
$1.07M 1.11%
10,974
-10,039
-48% -$915K
RHP icon
25
Ryman Hospitality Properties
RHP
$8.07B
$943K 0.98%
11,453
+4,919
+75% +$393K
1
2 3

Similar funds

CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
QI
Quilter Investors London, United Kingdom $22.3M AUM 6.63% 1-Year Est. Return
HWM
Highwater Wealth Management Glendale, Colorado $22.6M AUM 3.46% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
MAU
MRA Associates USA Phoenix, Arizona $25.4M AUM 0.38% 1-Year Est. Return
FCG
FrontFour Capital Group Greenwich, Connecticut $26.5M AUM 17.69% 1-Year Est. Return

Pacific View Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Pacific View Asset Management held 61 positions worth $96.3M, up 13% from $85.1M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Pacific View Asset Management's Q1 2019 filing shows 6 new, 24 increased, 18 reduced and 8 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 50,601 shares worth $5.66M. The largest sale was Loxo Oncology, Inc, an estimated $3.05M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 14% a quarter earlier, followed by Industrials and Financials.

  • Pacific View Asset Management's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 50,601 shares worth $5.66M.
  • Pacific View Asset Management added most to Sage Therapeutics in Q1 2019, an estimated $4.33M increase.
  • Pacific View Asset Management's biggest Q1 2019 reduction was Array Biopharma Inc, cutting an estimated $2.33M.
  • Pacific View Asset Management fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $3.05M.
  • Pacific View Asset Management's ten largest holdings make up 54% of its $96.3M portfolio in Q1 2019.
  • Pacific View Asset Management opened 6 new positions and closed 8 in Q1 2019.
  • Pacific View Asset Management's portfolio value rose 13% quarter-over-quarter to $96.3M.

Based on Pacific View Asset Management's 13F filing for Q1 2019, filed 15 May 2019.